Apex Biotechnology (TPE:1733) Dividend Payout Ratio: 3.51 (As of Jun. 2026) — 318% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:1733 Apex Biotechnology Corp TPE:1733
78 GF Score
Price NT$32.25
GF Value NT$30.05
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Apex Biotechnology Dividend Payout Ratio?

Apex Biotechnology TPE:1733 +0.47% 78 Dividend Payout Ratio is 3.51 as of Jun. 2026, which is 318% above its 10-year median of 0.84. GuruFocus rates TPE:1733 with a GF Score™ of 78/100 and a GF Value™ of NT$30.05 (Fairly Valued). The stock has 3 warning signs investors should review. Among 130 Biotechnology companies, Apex Biotechnology ranks worse than 70.77% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Apex Biotechnology's Dividend Payout Ratio for the months ended in Jun. 2026 was 3.51.

The historical rank and industry rank for Apex Biotechnology's Dividend Payout Ratio or its related term are showing as below:

TPE:1733' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.4   Med: 0.84   Max: 70.03
Current: 0.7

During the past 13 years, the highest Dividend Payout Ratio of Apex Biotechnology was 70.03. The lowest was 0.40. And the median was 0.84.

TPE:1733's Dividend Payout Ratio is ranked worse than
70.77% of 130 companies
in the Biotechnology industry
Industry Median: 0.45 vs TPE:1733: 0.70

As of today (2026-08-23), the Dividend Yield % of Apex Biotechnology is 4.03%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Apex Biotechnology was 10.92%. The lowest was 0.90%. And the median was 4.21%.

Apex Biotechnology's Dividends per Share for the months ended in Jun. 2026 was NT$1.30.

During the past 12 months, Apex Biotechnology's average Dividends Per Share Growth Rate was 8.30% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -2.60% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 1.40% per year. During the past 10 years, the average Dividends Per Share Growth Rate was -1.90% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Apex Biotechnology was 51.20% per year. The lowest was -54.10% per year. And the median was -5.10% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Apex Biotechnology (TPE:1733) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Apex Biotechnology Dividend Payout Ratio Related Terms

Apex Biotechnology Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Apex Biotechnology's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apex Biotechnology Dividend Payout Ratio Chart

Apex Biotechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.58 0.72 1.20 0.87 0.69

Apex Biotechnology Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.18 0.00 0.00 0.00 3.51

TPE:1733 vs VRTX, REGN, RVMD: Dividend Payout Ratio Comparison

For the Biotechnology subindustry, Apex Biotechnology's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Apex Biotechnology Dividend Payout Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Apex Biotechnology's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Apex Biotechnology's Dividend Payout Ratio falls into.


TPE:1733
78GF Score
Apex Biotechnology Corp TPE:1733
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apex Biotechnology Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Apex Biotechnology's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2025 )/ EPS without NRI (A: Dec. 2025 )
=1.2/ 1.742
=0.69

Apex Biotechnology's Dividend Payout Ratio for the quarter that ended in Jun. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2026 )/ EPS without NRI (Q: Jun. 2026 )
=1.3/ 0.37
=3.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 3.51 mean?
Apex Biotechnology (TPE:1733) has a Dividend Payout Ratio of 3.51 as of Jun. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Apex Biotechnology and its competitors. This is 318% above median its historical median of 0.84. Over the past decade, Apex Biotechnology's Dividend Payout Ratio has ranged from 0.40 to 70.03. According to the industry distribution chart, Apex Biotechnology ranks #92 out of 130 companies in the Biotechnology industry, placing it in the top 70.8%.
Is Apex Biotechnology's Dividend Payout Ratio too high?
Apex Biotechnology's current Dividend Payout Ratio of 3.51 is 318% above median its 10-year median of 0.84. Over the past 10 years, this metric has ranged from a low of 0.40 to a high of 70.03. The Biotechnology industry median Dividend Payout Ratio is 0.45. Apex Biotechnology's value of 3.51 is 680% above this industry median. Based on the distribution chart, Apex Biotechnology ranks #92 out of 130 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Apex Biotechnology has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Apex Biotechnology's Dividend Payout Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Apex Biotechnology ranks #92 out of 130 companies for Dividend Payout Ratio. This places Apex Biotechnology in the lower half of its industry. The industry median Dividend Payout Ratio is 0.45. Apex Biotechnology's value of 3.51 is 680% above this benchmark. Historically, Apex Biotechnology's own Dividend Payout Ratio has ranged from 0.40 to 70.03 over the past decade. While the company's 10-year median is 0.84 vs. the industry median of 0.45, Apex Biotechnology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Biotechnology company?
The median Dividend Payout Ratio among Biotechnology companies is 0.45, based on 130 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Apex Biotechnology's current Dividend Payout Ratio of 3.51 is 680% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Apex Biotechnology and its competitors. For the Biotechnology industry, the median Dividend Payout Ratio is 0.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apex Biotechnology's current Dividend Payout Ratio is 3.51, which is 318% above median its own 10-year median of 0.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apex Biotechnology stock overvalued right now?
Based on GuruFocus' analysis, Apex Biotechnology (TPE:1733) is currently considered Fairly Valued. The stock's GF Value™ is NT$30.05, compared to a current price of NT$32.25 — trading 7.3% above its estimated fair value. The current Dividend Payout Ratio is 3.51, which is 318% above median its 10-year median of 0.84 and 680% above the Biotechnology industry median of 0.45. Apex Biotechnology's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Apex Biotechnology (TPE:1733), the current Dividend Payout Ratio is 3.51 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Apex Biotechnology (TPE:1733) Overvalued in 2026?

Based on GuruFocus' analysis, Apex Biotechnology stock appears to be overvalued. The current stock price of NT$32.25 is trading 7.3% above its estimated GF Value™ of NT$30.05. GuruFocus considers Apex Biotechnology to be Fairly Valued.

Key valuation signals for TPE:1733:

  • Dividend Payout Ratio: 3.51 (318% above median its 10-year median of 0.84)
  • GF Value™: NT$30.05 vs. price of NT$32.25 (7.3% above fair value)
  • GF Score™: 78/100 with 3 warning signs
  • Industry Position: 680% above the Biotechnology median (#92 of 130)

No single metric tells the full story. See the TPE:1733 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Apex Biotechnology Business Description

Address Li-Hsin 5th Road, No. 7, Hsinchu Science Park, Hsinchu, TWN, 30078
Apex Biotechnology Corp is engaged in the research, development, production, manufacturing, and sale of biochemical testing instruments and proprietary test strips, as well as the import and export of products and components related to its core business. Its product offerings include diabetes testing kits, blood uric acid monitoring systems, blood lactate monitoring systems, blood haemoglobin monitoring systems, etc. The company generates maximum revenue from the sale of test strips, and the rest from testing meters, electrodes, and other products. Geographically, it derives maximum revenue from the USA, and the rest from Italy, Austria, Taiwan, China, and other markets.
78GF Score

Get the complete analysis for TPE:1733

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$32.25
Price
NT$30.05
GF Value